Coagulation and the expression of cell-mediated immunity

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Cell-mediated immunity (CMI) activation can induce monocyte/macrophage procoagulants.
• Macrophage procoagulant inducing factor (MPIF), a lymphokine, may contribute to fibrin deposition in CMI-driven diseases.
• Interleukin 1 and tumor necrosis factor alpha also play roles in initiating thromboplastin on endothelial cells.

Purpose of the Study:

• To investigate the role of Macrophage procoagulant inducing factor (MPIF) in the cell-mediated immune response.
• To characterize the biochemical properties of murine MPIF.
• To determine the in vivo and in vitro effects of MPIF on immune cell infiltration and coagulation.

Main Methods:

• Characterization of murine MPIF's biochemical properties, including heparin-binding and isoelectric points.
• Intradermal injection of MPIF-enriched fractions in mice to assess fibrin deposition and cellular infiltration.
• In vitro experiments to evaluate MPIF's chemotactic activity on immune cells.

Main Results:

• Murine MPIF exhibits distinct properties, being heparin-binding proteins with high isoelectric points.
• Intradermal MPIF injection led to interstitial fibrin deposition and significant infiltration of polymorphonuclear and mononuclear cells.
• In vitro studies confirmed MPIF as a potent chemotactic agent for these cells.

Conclusions:

• MPIF plays a central role in the histopathological features of delayed-type hypersensitivity reactions.
• MPIF-induced procoagulants contribute to coagulation activation, fibrin deposition, and potentiation of inflammatory responses.
• MPIF's actions highlight its significance in immune-mediated inflammatory processes.